C61
BillableMalignant neoplasm of prostate
Malignant neoplasm of prostate
Coding Notes
Includes
Conditions included under this code
- malignant neoplasm of skin of male genital organs
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Use Additional Code
Additional codes that should follow this code
- code, if applicable, to identify:
- •hormone sensitivity statusZ19.1-Z19.2
- •rising PSA following treatment for malignant neoplasm of prostateR97.21
ICD-11 Equivalents(1)
ICD-11 Equivalents
View full mappingCorresponding ICD-11 codes from the WHO crosswalk mapping
Also Known As / Clinical Terms(244)
SNOMED CT
- Primary malignant neoplasm of prostate93974005
- Malignant neoplasm of seminal vesicle188234005
- Malignant tumor of seminal vesicle188234005
- Malignant tumour of seminal vesicle188234005
- Neoplasm of seminal vesicle236740006
- Tumor of seminal vesicle236740006
- Tumour of seminal vesicle236740006
- CA - Carcinoma of prostate254900004
- Carcinoma of prostate254900004
- Prostate carcinoma254900004
- Endometrioid carcinoma of prostate278060005
- Local recurrence of malignant neoplasm of prostate314969001
- Local recurrence of malignant tumor of prostate314969001
- Local recurrence of malignant tumour of prostate314969001
- Malignant tumor involving rectum by direct extension from prostate369451000
- Malignant tumour involving rectum by direct extension from prostate369451000
- Malignant tumor involving urethra by direct extension from prostate369466002
- Malignant tumour involving urethra by direct extension from prostate369466002
- Malignant neoplasm involving urinary bladder by direct extension from prostate369472002
- Malignant tumor involving bladder by direct extension from prostate369472002
- Malignant tumour involving bladder by direct extension from prostate369472002
- Malignant tumor involving vasa deferentia by direct extension from prostate369483006
- Malignant tumour involving vasa deferentia by direct extension from prostate369483006
- Malignant tumor involving seminal vesicle by direct extension from prostate369490001
- Malignant tumour involving seminal vesicle by direct extension from prostate369490001
- Malignant tumor involving an organ by direct extension from prostate369598006
- Malignant tumour involving an organ by direct extension from prostate369598006
- Periprostatic fat invasion by tumor absent372290003
- Periprostatic fat invasion by tumour absent372290003
- Prostate tumor invasion of periprostatic fat absent372290003
- Prostate tumour invasion of periprostatic fat absent372290003
- Tumor invasion of periprostatic fat absent (prostate)372290003
- Tumour invasion of periprostatic fat absent (prostate)372290003
- Invasion of perineural tissue by prostate tumor present372296009
- Invasion of perineural tissue by prostate tumour present372296009
- Tumor invasion of perineural tissue present (prostate)372296009
- Tumour invasion of perineural tissue present (prostate)372296009
- No invasion of perineural tissue by prostate tumor372297000
- No invasion of perineural tissue by prostate tumour372297000
- Tumor invasion of perineural tissue absent (prostate)372297000
- Tumour invasion of perineural tissue absent (prostate)372297000
- Extraprostatic extension of tumor present372306004
- Extraprostatic extension of tumour present372306004
- Extraprostatic extension of tumor present, unifocal385015003
- Extraprostatic extension of tumour present, unifocal385015003
- Extraprostatic extension of tumor present, multifocal385016002
- Extraprostatic extension of tumour present, multifocal385016002
- Cancer of prostate399068003
- Malignant neoplasm of prostate399068003
- Malignant prostatic tumor399068003
- Malignant prostatic tumour399068003
- Malignant tumor of prostate399068003
- Malignant tumour of prostate399068003
- Adenocarcinoma of prostate399490008
- Squamous cell carcinoma of prostate399590005
- Extraprostatic extension of tumor present, focal420366008
- Extraprostatic extension of tumour present, focal420366008
- Extraprostatic extension of tumor present, non-focal420387003
- Extraprostatic extension of tumour present, non-focal420387003
- Castrate-resistant prostate cancer427492003
- Castration-resistant prostate cancer427492003
- Hormone refractory prostate cancer427492003
- Familial malignant neoplasm of prostate715412008
- Familial prostate cancer715412008
- Obstructive nephropathy due to carcinoma of prostate722081007
- Obstructive nephropathy due to prostate cancer722081007
- Obstructive nephropathy due to malignancy722088001
- Castrate-sensitive prostate cancer722103009
- Castration-sensitive prostate cancer722103009
- Hormone sensitive prostate cancer722103009
- Acinar cell cystadenocarcinoma of prostate822970008
- Duct adenocarcinoma of prostate823017009
- Ductal carcinoma of prostate823017009
- Infiltrating duct adenocarcinoma of prostate823017009
- Infiltrating duct carcinoma of prostate823017009
- Squamous cell carcinoma of male genital1148901006
- Primary carcinoma of prostate1259388006
- Primary prostate cancer1259388006
- Primary prostate carcinoma1259388006
- Primary acinar cell cystadenocarcinoma of prostate1259666003
- Primary duct adenocarcinoma of prostate1259669005
- Primary ductal carcinoma of prostate1259669005
- Primary infiltrating duct adenocarcinoma of prostate1259669005
- Primary infiltrating duct carcinoma of prostate1259669005
- Primary adenocarcinoma of prostate1259672003
- Primary endometrioid carcinoma of prostate1259674002
- Biochemical recurrence of malignant neoplasm of prostate461511000124101
- Biochemical relapse of malignant neoplasm of prostate461511000124101
- Biochemically recurrent prostate cancer461511000124101
- Non-metastatic prostate cancer461511000124101
- Rising prostate specific antigen (PSA) state461511000124101
- Metastasis from hormone-refractory prostate cancer459381000124106
- Metastatic castration-resistant prostate cancer459381000124106
- Metastatic hormone refractory prostate cancer459381000124106
- Primary malignant hormone-refractory neoplasm of prostate681221000124106
- Prostate cancer metastatic to eye96901000119105
- Recurrent malignant neoplasm of prostate1098981000119101
UMLS
- Cancer of ProstateC0376358
- Cancer of prostateC0376358
- Cancer of the ProstateC0376358
- Cancer of the prostateC0376358
- Cancer, ProstateC0376358
- Cancer, ProstaticC0376358
- Cancers, ProstateC0376358
- Cancers, ProstaticC0376358
- Malignant Neoplasm of ProstateC0376358
- Malignant Neoplasm of the ProstateC0376358
- Malignant Prostate NeoplasmC0376358
- Malignant Prostate TumorC0376358
- Malignant Tumor of ProstateC0376358
- Malignant Tumor of the ProstateC0376358
- Malignant neoplasm of prostateC0376358
- Malignant neoplasm of prostate (disorder)C0376358
- Malignant neoplasm of the prostateC0376358
- Malignant prostatic tumorC0376358
- Malignant prostatic tumourC0376358
- Malignant tumor of prostateC0376358
- Malignant tumour of prostateC0376358
- PROSTATE CANCERC0376358
- Prostate CancerC0376358
- Prostate CancersC0376358
- Prostate cancerC0376358
- Prostate cancer NOSC0376358
- Prostatic CancerC0376358
- Prostatic CancersC0376358
- Prostatic cancerC0376358
- Prostatic neoplasms malignantC0376358
- cancer of prostateC0376358
- cancer of the prostateC0376358
- malignant neoplasm of prostateC0376358
- prostate cancerC0376358
- prostatic cancerC0376358
Clinical Terms
- Metastatic castration-resistant prostate cancer
- Adenocarcinoma of prostate
- Primary infiltrating duct adenocarcinoma of prostate
- Malignant Tumor of the Prostate
- Primary duct adenocarcinoma of prostate
- Extraprostatic extension of tumour present, non-focal
- prostate cancer
- Primary prostate carcinoma
- cancer of the prostate
- Endometrioid carcinoma of prostate
- Prostate tumor invasion of periprostatic fat absent
- Prostate carcinoma
- Infiltrating duct carcinoma of prostate
- Extraprostatic extension of tumor present, focal
- Tumor invasion of perineural tissue absent (prostate)
- Malignant tumor of prostate
- Periprostatic fat invasion by tumor absent
- Extraprostatic extension of tumor present, non-focal
- Prostatic cancer
- Primary malignant hormone-refractory neoplasm of prostate
- Castration-resistant prostate cancer
- No invasion of perineural tissue by prostate tumour
- Extraprostatic extension of tumor present, multifocal
- Periprostatic fat invasion by tumour absent
- Primary acinar cell cystadenocarcinoma of prostate
- Cancer of Prostate
- Malignant tumour involving an organ by direct extension from prostate
- Primary malignant neoplasm of prostate
- Primary ductal carcinoma of prostate
- Biochemically recurrent prostate cancer
- Ductal carcinoma of prostate
- Tumour of seminal vesicle
- Malignant tumor involving urethra by direct extension from prostate
- Prostate cancer NOS
- Carcinoma of prostate
- Malignant tumor involving vasa deferentia by direct extension from prostate
- Tumour invasion of periprostatic fat absent (prostate)
- Biochemical recurrence of malignant neoplasm of prostate
- Malignant tumor involving seminal vesicle by direct extension from prostate
- Local recurrence of malignant tumour of prostate
- Tumour invasion of perineural tissue present (prostate)
- Duct adenocarcinoma of prostate
- CA - Carcinoma of prostate
- No invasion of perineural tissue by prostate tumor
- Primary adenocarcinoma of prostate
- Malignant Prostate Tumor
- Extraprostatic extension of tumour present, focal
- Malignant Neoplasm of the Prostate
- Obstructive nephropathy due to carcinoma of prostate
- Malignant tumour involving vasa deferentia by direct extension from prostate
- Local recurrence of malignant neoplasm of prostate
- Malignant tumour of seminal vesicle
- Neoplasm of seminal vesicle
- Extraprostatic extension of tumour present, unifocal
- Familial malignant neoplasm of prostate
- Prostate cancer metastatic to eye
- Tumor of seminal vesicle
- Extraprostatic extension of tumour present
- Prostatic Cancers
- Malignant tumor involving bladder by direct extension from prostate
- Cancers, Prostate
- Familial prostate cancer
- Rising prostate specific antigen (PSA) state
- Local recurrence of malignant tumor of prostate
- Tumor invasion of periprostatic fat absent (prostate)
- Malignant tumour of prostate
- Hormone sensitive prostate cancer
- Cancers, Prostatic
- Malignant tumor of seminal vesicle
- Castration-sensitive prostate cancer
- Obstructive nephropathy due to malignancy
- Primary infiltrating duct carcinoma of prostate
- Extraprostatic extension of tumour present, multifocal
- Malignant neoplasm of prostate (disorder)
- Invasion of perineural tissue by prostate tumor present
- Biochemical relapse of malignant neoplasm of prostate
- Invasion of perineural tissue by prostate tumour present
- Malignant tumour involving bladder by direct extension from prostate
- Recurrent malignant neoplasm of prostate
- Malignant tumour involving urethra by direct extension from prostate
- Prostate tumour invasion of periprostatic fat absent
- Infiltrating duct adenocarcinoma of prostate
- Non-metastatic prostate cancer
- Cancer, Prostatic
- Malignant neoplasm of seminal vesicle
- Malignant tumor involving an organ by direct extension from prostate
- Extraprostatic extension of tumor present, unifocal
- Malignant tumour involving rectum by direct extension from prostate
- Metastasis from hormone-refractory prostate cancer
- Castrate-resistant prostate cancer
- Malignant prostatic tumour
- Prostatic neoplasms malignant
- Squamous cell carcinoma of prostate
- Tumor invasion of perineural tissue present (prostate)
- Malignant prostatic tumor
- Primary prostate cancer
- Malignant tumour involving seminal vesicle by direct extension from prostate
- Prostate Cancers
- Metastatic hormone refractory prostate cancer
- Malignant neoplasm involving urinary bladder by direct extension from prostate
- Acinar cell cystadenocarcinoma of prostate
- Primary endometrioid carcinoma of prostate
- Malignant tumor involving rectum by direct extension from prostate
- Obstructive nephropathy due to prostate cancer
- Cancer, Prostate
- Squamous cell carcinoma of male genital
- Castrate-sensitive prostate cancer
- Malignant Prostate Neoplasm
- Tumour invasion of perineural tissue absent (prostate)
- Extraprostatic extension of tumor present
- Primary carcinoma of prostate
- Hormone refractory prostate cancer
Frequently Asked Questions
What is the ICD-10 code for malignant neoplasm of prostate?
The ICD-10-CM code for malignant neoplasm of prostate is C61. The full clinical description is "Malignant neoplasm of prostate". C61 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code C61 mean?
ICD-10-CM code C61 represents “Malignant neoplasm of prostate”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.
Is C61 a billable code?
Yes, C61 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is C61 in?
C61 is in Chapter 2: Neoplasms (codes C00-D49).
What codes cannot be used with C61?
C61 has Excludes1 notes indicating codes that cannot be used together with it, including: malignant neoplasm of seminal vesicle (C63.7).
Are additional codes required with C61?
Yes, when using C61, also report: code, if applicable, to identify:; hormone sensitivity status (Z19.1-Z19.2); rising PSA following treatment for malignant neoplasm of prostate (R97.21).
What SNOMED CT codes does C61 map to?
C61 maps to 41 SNOMED CT concepts: 822970008, 399490008, 461511000124101, 254900004, 399068003, and 36 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for C61?
C61 is linked to 1 UMLS Concept Unique Identifier: C0376358. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does C61 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like malignant neoplasm of prostate affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of C61?
C61 maps to the ICD-11 code: 2C82.Z (Malignant neoplasms of prostate, unspecified).
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.